Notably, we show that both NKG2D and its ligands are upregulated specifically in the more immunogenic CMS1 CRC tumors, and that expression of these genes is associated with the upregulation of immune checkpoint molecules, including PD-1. Here, PDCD1 is linked to colorectal carcinoma.